Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | UK Health Security Agency |
| Main Category: | Goods |
| Procurement Method: | Call-off from a dynamic purchasing system |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
Awarded to
| Award value: | £1 |
| Award decision date: | 18 September 2025 |
| Award status: | Active |
Contract for the supply of immunisation products indicated for the prevention of, or protection against, SARS-CoV-2 in Adults (2025/26). The contract was awarded for Lot 2, Adult SARS-CoV-2 vaccines, via a further competition conducted under the SARS-CoV-2 vaccine DPS (FTS ref: 2024/S 000-026083). Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Published contracts in the last 12 months
289
total contracts
£440.3m
total value
£1,719,777
average contract size
Typical categories
Request for Information - Lyophilisation services
UK Health Security Agency · WAC-618288
Request for Information - Lyophilisation services
UK Health Security Agency · WAC-618289
Request for Information - Oligonucleotides Onshoring
UK Health Security Agency · WAC-611114
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
20 February 2025
Closed
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Release Date: | 17 December 2025 |
| Application Deadline: | 20 February 2025 |
| Contract Start Date: | 18 September 2025 |
| Contract End Date: | 19 December 2026 |
| Contract Duration: | 1.3 years |
| Procurement ID (OCID): | ocds-b5fd17-f0ad0a1e-2d06-4f7f-a0a8-57b2bab2cb2a |
| Notice Reference: | 677a9636-a239-410b-aac4-5cda20fe1a46-876285 |
View Original Notice
Access the full notice on the official portal